| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/27/2005 | CN1609102A Optically active amlodipine resolving process |
| 04/27/2005 | CN1608652A Medicine for preventing and treating cardiac and cerebral vascular diseases |
| 04/27/2005 | CN1608650A Chinese medicine for treating coronary heart disease and angina pectoris |
| 04/27/2005 | CN1608646A Wolfberry fruit-astragalus root oral liquid and its prepn process |
| 04/27/2005 | CN1608638A Blood cleaning metabolism bolus |
| 04/27/2005 | CN1608631A Recipe of medicine for treating piles |
| 04/27/2005 | CN1608629A Compound panoxatriol saponin with physiological activity and its prepn and use |
| 04/27/2005 | CN1608622A Solid dispersed Nimoldipine tablet and its prepn process |
| 04/27/2005 | CN1198827C Selected derivatives of K-252a |
| 04/27/2005 | CN1198825C 8-pheyl-6,9-dihydro-[1,2,4]triazolo[3,4-i] purin-5-one derivatives |
| 04/27/2005 | CN1198819C Benzimidazole derivatives |
| 04/27/2005 | CN1198818C Compound with growth hormone releasing properties |
| 04/27/2005 | CN1198817C N-(imidazolylalkyl) substituted cyclic amines as histamine-H3 agonists or antagonists |
| 04/27/2005 | CN1198814C Salt |
| 04/27/2005 | CN1198813C Benzofuran derivatives their preparation and use |
| 04/27/2005 | CN1198804C Amide compounds and use thereof |
| 04/27/2005 | CN1198799C Crystalline form of (S)-2-ethoxy-3-[4-(2-{4-methane sulfonyloxy phenyl}ethoxy)phenyl] propanoic acid |
| 04/27/2005 | CN1198640C Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| 04/27/2005 | CN1198637C Health cosmetic composition |
| 04/27/2005 | CN1198635C Chinese medicine haemorrhoids ointment |
| 04/27/2005 | CN1198622C Steroidal saponins for treating alzheimer's disease and derivatives thereof |
| 04/27/2005 | CN1198619C Application of benzoaza-N-acetic acid derivative in preparation of medicine for treating pulmonary hypertension |
| 04/27/2005 | CN1198613C Aminophenoxyacetic acid derivatives and pharmaceutical composition containing the same |
| 04/27/2005 | CN1198605C Compound with 5-HT1A activity useful for treating disorders of outer retina |
| 04/27/2005 | CN1198604C Application of 1-heptanol in preparing medicine for acute and chronic cerebrovascular spasm |
| 04/27/2005 | CN1198598C Hydrophilic/lipophilic polymeric matrix dosage |
| 04/27/2005 | CN1198596C Sustained release formulations for 24 hours release of metoprolol |
| 04/27/2005 | CN1198591C Bioenhanced formulations comprising eprosartan in oral dosage form |
| 04/27/2005 | CN1198589C Method for controlling liposome size |
| 04/26/2005 | US6884907 Containing carboxylic acid groups; diagnosis; prophylaxis |
| 04/26/2005 | US6884809 Method and compositions for reducing cardiac dysfunctions with a selective histamine H3 receptor agonist |
| 04/26/2005 | US6884807 3-bicyclic carbocyclic group substituted quinuclidine derivatives, which are cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptor and transporters |
| 04/26/2005 | US6884806 Treatment of rheumatoid and osteoarthritis, corneal, epidermal or gastric ulceration, tumor metastasis, periodontal disease, bone disease |
| 04/26/2005 | US6884802 Phenanthridines substituted in position 6 by a mono, bi- or tricyclic heteroaryl radical; cyclic nucleotidephosphoesterase (PDE4) inhibitor and useful for treating respiratory system disorders |
| 04/26/2005 | US6884800 Nitrogen compounds such as 10-Chloro-3-imidazol-1-yl-2,3-dihydro-1H-pyrido(3,2,1-kl)phenothiazine, used for prophylaxis of respiratory system and skin disorders, autoimune diseases, tumors or atherosclerosis and AIDS |
| 04/26/2005 | US6884795 Pharmaceutical compositions and uses for androst-5-ene-3β, 17β-diol |
| 04/26/2005 | US6884773 Modified hemoglobins, including nitrosylhemoglobins, and uses thereof |
| 04/26/2005 | US6884431 Method for treating proliferative diseases with p27 and fusions thereof |
| 04/26/2005 | CA2125251C A pharmaceutical composition for angiotensin ii-mediated diseases |
| 04/26/2005 | CA2123052C Monomeric bile acid derivatives, processes for their preparation and the use of these compounds as medicaments |
| 04/21/2005 | WO2005035536A1 Novel xanthone derivative, process for producing the same and pharmaceutical composition containing the same |
| 04/21/2005 | WO2005035534A1 Heterocyclic bicyclo ring and heterocyclic tricyclo ring compounds and drugs comprising the same |
| 04/21/2005 | WO2005035503A1 Novel isoquinoline derivative |
| 04/21/2005 | WO2005035498A1 Use of nitrogenous bicyclic compound as feeding control agent |
| 04/21/2005 | WO2005034986A1 Remedy for kidney diseases |
| 04/21/2005 | WO2005034985A1 Agent for improving mental disorders |
| 04/21/2005 | WO2005034975A1 Plant seed extract composition and process for producing the same |
| 04/21/2005 | WO2005034946A1 Nonsedating α-2 agonist 1- (2, 3-dimethyl-phenyl) -ethyl-1, 3-dihydro-imizadole-2-thione |
| 04/21/2005 | WO2005034936A1 Use of l-butylphthalide in the manufacture of medicaments for prevention and treatment of cerebral infarct |
| 04/21/2005 | WO2005034929A2 Tissue remodeling and vascularization |
| 04/21/2005 | WO2005034918A1 Pellets containing a pharmaceutical ingredient |
| 04/21/2005 | WO2005034866A2 Preparation of 1, 6, 7- trisubstituted azabenzimidazoles as kinase inhibitors |
| 04/21/2005 | WO2005034837A2 7H-IMIDAZO [1,2-α] PYRAZIN-8-ONE COMPOUNDS AS ION CHANNEL MODULATORS |
| 04/21/2005 | WO2005010047A3 Antiangiogenic compounds, pharmaceutical composition containing said compounds and the use thereof |
| 04/21/2005 | WO2005004884A3 Use of nitrite salts for the treatment of cardiovascular conditions |
| 04/21/2005 | WO2004093995A3 Use of antioxidants to treat bone loss disorders |
| 04/21/2005 | WO2004078942A3 Endothelial cell specific antibodies and uses thereof |
| 04/21/2005 | WO2004078169A8 Use of ep2 selective receptor agonists in medical treatment |
| 04/21/2005 | WO2004005313A3 Hybrid molecules of macrolides with steroid/non-steroid anti-inflammatory, antineoplastic and antiviral active molecules |
| 04/21/2005 | WO2002098348A3 Glp-1 formulations with protracted time action |
| 04/21/2005 | US20050085639 Circulation disorders; antiproliferative agents; hypotensive agents; cardiovascular disorders; antiischemic agents; kidney disorders; atherosclerosis; restenosis; antiinflammatory agents; respiratory system disorders; angiogenesis inhibitors; anticancer agents; antiulcer agents |
| 04/21/2005 | US20050085637 Pyrimidine compounds |
| 04/21/2005 | US20050085548 Administering mixture of arginine and reductase inhibitase; therapy for endothelial cell diseases; hypotensive agents; cardiovascular disorders brain disorders |
| 04/21/2005 | US20050085541 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof |
| 04/21/2005 | US20050085533 Central nervous system disorders; cardiovascular disorders; gastrointestinal disorders |
| 04/21/2005 | US20050085532 Prevention, therapy of central nervous system disorders ; antidepressants; anxiolytic agents; eating and sleep disorders; Alzheimer's disease; strokes; schizophrenia; incontinence; gastrointestinal disorders; cardiovascular disorders |
| 04/21/2005 | US20050085520 amidation and/or dehalogenation to form substituted [4-carbamoyl-2-hydroxypentyl]-benzamides; potent enzyme inhibitors of Asp2 [B-secretase, BACE1 (b-site Alzheimer's amyloid precursor protein cleaving enzyme) or Memapsin]; Alzheimer's disease |
| 04/21/2005 | US20050085509 KInase inhibitors; antiarthritic agents; autoimmune diseases; sepsis; cachexia; Alzheimer's disease; antihistamines; thrombosis; glomerulonephritis; inflammatory bowel disorders; crohn's disese; multiple sclerosis; antitumor agents; skin disorders |
| 04/21/2005 | US20050085503 used for detecting diseases where N-acetylated alpha -linked acidic dipeptidase (NAALADase) levels are altered, effecting neuronal activity, effecting TGF- beta activity, inhibiting angiogenesis, and treating glutamate abnormalities, cancer, pain |
| 04/21/2005 | US20050085489 Pharmaceutical composition comprising a glitazone and a 4-oxobutanoic acid, and the use thereof for treating diabetes |
| 04/21/2005 | US20050085487 Heterocyclic compounds |
| 04/21/2005 | US20050085481 1-(aminoalkyl)-3-sulfonylazaindoles as 5-hydroxytryptamine-6 ligands |
| 04/21/2005 | US20050085480 Water-soluble phenylpyridazine compounds and compositions containing the same |
| 04/21/2005 | US20050085478 Compositions of a cyclooxygenase-2 selective inhibitor and a low-molecular-weight heparin for the treatment of central nervous system damage |
| 04/21/2005 | US20050085476 Polymerase inhibitors; antiischemic agents; brain disorders; cardiovascular disorders; antiinflammatory agents; antiarthritic agents; neurodegenerative agents; Alzheimer's disease; muscular disorders; antidiabetic agents; kidney disorders; viricides; anticancer agents; immunosuppressants |
| 04/21/2005 | US20050085471 Using 2-morpholinyl-4H-pyrido(1,2-a)pyrimidin-4-one; enzyme inhibitors; antithrombotic agents ; restenosis; atherosclerosis; antihistamines; chronic obsessive pulminary disease; autoimmune diseases; anticancer agents; antiinflammatory agents |
| 04/21/2005 | US20050085465 Quinazoline compounds |
| 04/21/2005 | US20050085460 useful as therapeutics in treatment of cancers and the amelioration of the effects of stroke, head trauma, and neurodegenerative disease |
| 04/21/2005 | US20050085457 Therapeutic quinolone compounds with 5-ht-antagonistic properties |
| 04/21/2005 | US20050085426 Acid-sensitive compounds, preparation and use thereof |
| 04/21/2005 | US20050085408 Drugs ameliorating hypo-hdl cholesterolemia |
| 04/21/2005 | US20050084860 Inhibition of tristetraproline for protection of the heart from cardiac injuries |
| 04/21/2005 | US20050084552 Pharmaceutical composition of chinese herbs for treating snuffle, headache and the use thereof |
| 04/21/2005 | US20050084489 Synergistic administration of Vitaxin, a FAB fragment, or a competitive binding antibody for binding integrin alpha V beta 3 with the enzyme inhibitor; antiinflammatory, anticarcinogenic agents; autoimmune and metabolic bone disorders |
| 04/21/2005 | US20050084463 Antiinflammatory, antiarthritic agents, analgesics for pain caused by diabetic assoicated conditions, pneumoconiosis, angina, menstruation or cancer |
| 04/21/2005 | CA2549931A1 Use of l-butylphthalide in the manufacture of medicaments for prevention and treatment of cerebral infarct |
| 04/21/2005 | CA2541607A1 Therapeutic agents for renal diseases |
| 04/21/2005 | CA2541603A1 Agent for improving mental disorders |
| 04/21/2005 | CA2540849A1 Plant seed extract composition and process for producing the same |
| 04/21/2005 | CA2539681A1 Nucleic acid molecules encoding novel human low-voltage activated calcium channel proteins, designated - alpha 1i-1 and alpha 1i-2, encoded proteins and methods of use thereof |
| 04/20/2005 | EP1524263A1 prodrugs containing cycloalkene derivatives |
| 04/20/2005 | EP1523988A1 A composition containing radix codonopsis pilosulae and radix astragali and hedysari, method of producing it and use thereof |
| 04/20/2005 | EP1523983A1 Pharmaceutical composition comprising fenofibrate and process for its preparation |
| 04/20/2005 | EP1523982A2 Plenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |
| 04/20/2005 | EP1523980A2 Use of glucose uptake enhancer for reducing post-ischemic injury of the heart |
| 04/20/2005 | EP1523556A1 Methods of treating conditions associated with an edg-1 receptor |
| 04/20/2005 | EP1523541A1 A process for decreasing environmental pollutants in an oil or a fat, a volatile environmental pollutants decreasing working fluid, a health supplement, and an animal feed product |
| 04/20/2005 | EP1523488A1 Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof |
| 04/20/2005 | EP1523484A2 3-phenyl analogs of toxoflavine as kinase inhibitors |
| 04/20/2005 | EP1523483A2 Amino-bicyclic pyrazinones and pyridinones as coagulation serine protease inhibitors |